Cited by 5Per- and polyfluoroalkyl substances researchLiver Disease Diagnosis and TreatmentFluorine in Organic Chemistry

Associations of Perfluoroalkyl Substances with Metabolic-Associated Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease: NHANES 2017–2018

Zhang, Yuxiao, Zhang, Min, Jiang, Shanjiamei, Hu, Heng, Wang, Xinzhi, Yu, Fan, Huang, Yue’e, Liang, Yali·2024·Cancer Causes & Control

Abstract

Objectives This study investigated the potential effects of perfluoroalkyl substance (PFAS) in serum on MAFLD, NAFLD, and liver fibrosis.Methods Our sample included 696 participants (≥ 18 years) from the 2017-2018 NHANES study with available serum PFASs, covariates, and outcomes. Using the first quartile of PFAS as the reference group, we used weighted binary logistic regression and multiple ordered logistic regression used to analyze the relationship between PFAS and MAFLD, NAFLD, and liver fibrosis and multiple ordinal logistic regression to investigate the relationship between PFAS and MAFLD, NAFLD, and liver fibrosis and calculated the odds ratio (OR) and 95% confidence interval for each chemical. Finally, stratified analysis and sensitivity analysis were performed according to gender, age, BMI, and serum cotinine concentration.Results A total of 696 study subjects were included, including 212 NAFLD patients (weighted 27.03%) and 253 MAFLD patients (weighted 32.65%). The quartile 2 of serum PFOA was positively correlated with MAFLD and NAFLD (MAFLD, OR 2.29, 95% CI 1.05-4.98; NAFLD, OR 2.37, 95% CI 1.03-5.47). PFAS were not significantly associated with liver fibrosis after adjusting for potential confounders in MAFLD and NAFLD. Stratified analysis showed that PFOA was strongly associated with MAFLD, NAFLD, and liver fibrosis in males and obese subjects. In women over 60 years old, PFHxS was also correlated with MAFLD, NAFLD, and liver fibrosis.Conclusion The serum PFOA was positively associated with MAFLD and NAFLD in US adults. After stratified analysis, the serum PFHxS was correlated with MFALD, NAFLD, and liver fibrosis.

Integrity signals

Registry

Crossref · 10.1007/s10552-024-01865-5

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These effects contribute to the development of metabolic-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD).

    “These effects contribute to the development of metabolic-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD).”
  • Human and animal studies consistently show elevated liver enzymes, hepatic fat accumulation, and disruptions in lipid and bile acid metabolism, even among children without traditional metabolic risk factors.

    “Human and animal studies consistently show elevated liver enzymes, hepatic fat accumulation, and disruptions in lipid and bile acid metabolism, even among children without traditional metabolic risk factors [77].”

Cites

1 retracted

Flagged first, then by citations

1 of the 69 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Zhang, Y., Zhang, M., Jiang, S., Hu, H., Wang, X., Yu, F., Huang, Y., & Liang, Y.
Affiliations
  • Wannan Medical College (CN)
  • First Affiliated Hospital of Wannan Medical College (CN)
Corresponding author
  • Huang, Yue’e
  • Liang, Yali
Venue
Cancer Causes & Control
Published
2024-05-19
Volume
35
Issue
9
Pages
1271-1282
ISSN
  • 0957-5243 (ISSN-L)
  • 1573-7225
OpenAlex
W4397290553
Cited by
5
References
69
Citations by year
2026: 2 · 2025: 3
FWCI
0.66
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Causes & Control (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Anhui Province University Collaborative Innovation Project (GXXT-2021-087)
  • Anhui Provincial Quality Engineering for Colleges and Universities (2019zyrc063)
  • Quality Engineering Project of Wannan Medical College (2019ylzy01)
  • Key Projects of Anhui Provincial Department of Education (KJ2021A0836)
  • Key scientific research project of Wannan Medical College (grant number WK2020Z07)
Topics
  • Physical Sciences › Environmental Science › Environmental Chemistry › Per- and polyfluoroalkyl substances research
  • Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Fluorine in Organic Chemistry
Keywords
perfluorinated compounds, perfluorooctanoic acid, PFHxS, non-alcoholic fatty liver disease, liver fibrosis, obesity, sex differences, NHANES
MeSH terms
Adult, Aged, Cross-Sectional Studies, Female, Fluorocarbons, Humans, Liver Cirrhosis, Male, Middle Aged, Nutrition Surveys, United States, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review